These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7633186)

  • 1. Muscle X-inactivation patterns and dystrophin expression in Duchenne muscular dystrophy carriers.
    Matthews PM; Benjamin D; Van Bakel I; Squier MV; Nicholson LV; Sewry C; Barnes PR; Hopkin J; Brown R; Hilton-Jones D
    Neuromuscul Disord; 1995 May; 5(3):209-20. PubMed ID: 7633186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X inactivation and dystrophin studies in a t(X;12) female: evidence for biochemical normalization in Duchenne muscular dystrophy carriers.
    Wenger SL; Steele MW; Hoffman EP; Barmada MA; Wessel HB
    Am J Med Genet; 1992 Aug; 43(6):1012-5. PubMed ID: 1415326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype.
    Brioschi S; Gualandi F; Scotton C; Armaroli A; Bovolenta M; Falzarano MS; Sabatelli P; Selvatici R; D'Amico A; Pane M; Ricci G; Siciliano G; Tedeschi S; Pini A; Vercelli L; De Grandis D; Mercuri E; Bertini E; Merlini L; Mongini T; Ferlini A
    BMC Med Genet; 2012 Aug; 13():73. PubMed ID: 22894145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of dystrophin-associated glycoproteins and utrophin in carriers of Duchenne muscular dystrophy.
    Sewry CA; Matsumura K; Campbell KP; Dubowitz V
    Neuromuscul Disord; 1994; 4(5-6):401-9. PubMed ID: 7881285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dystrophin immunofluorescence pattern in manifesting and asymptomatic carriers of Duchenne's and Becker muscular dystrophies of different ages.
    Vainzof M; Pavanello RC; Pavanello I; Tsanaclis AM; Levy JA; Passos-Bueno MR; Rapaport D; Zatz M
    Neuromuscul Disord; 1991; 1(3):177-83. PubMed ID: 1822792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
    Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
    Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manifesting carriers of Xp21 muscular dystrophy; lack of correlation between dystrophin expression and clinical weakness.
    Sewry CA; Sansome A; Clerk A; Sherratt TG; Hasson N; Rodillo E; Heckmatt JZ; Strong PN; Dubowitz V
    Neuromuscul Disord; 1993 Mar; 3(2):141-8. PubMed ID: 8358239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of a female manifesting Becker muscular dystrophy.
    Glass IA; Nicholson LV; Watkiss E; Johnson MA; Roberts RG; Abbs S; Brittain-Jones S; Boddie HG
    J Med Genet; 1992 Aug; 29(8):578-82. PubMed ID: 1518025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophy: evidence for failure of dystrophin production in dystrophin-competent myonuclei.
    Pegoraro E; Schimke RN; Garcia C; Stern H; Cadaldini M; Angelini C; Barbosa E; Carroll J; Marks WA; Neville HE; Marks H; Appleton S; Toriello H; Wessel HB; Donnelly J; Bernes SM; Taber JW; Weiss L; Hoffman EP
    Neurology; 1995 Apr; 45(4):677-90. PubMed ID: 7723955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of dystrophin in carriers of Duchenne muscular dystrophy.
    Clerk A; Rodillo E; Heckmatt JZ; Dubowitz V; Strong PN; Sewry CA
    J Neurol Sci; 1991 Apr; 102(2):197-205. PubMed ID: 2072119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of X-chromosome inactivation in Duchenne muscle/myocardium-manifesting carriers, non-manifesting carriers and related daughters.
    Viggiano E; Picillo E; Cirillo A; Politano L
    Clin Genet; 2013 Sep; 84(3):265-70. PubMed ID: 23110537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability in clinical, genetic and protein abnormalities in manifesting carriers of Duchenne and Becker muscular dystrophy.
    Bushby KM; Goodship JA; Nicholson LV; Johnson MA; Haggerty ID; Gardner-Medwin D
    Neuromuscul Disord; 1993 Jan; 3(1):57-64. PubMed ID: 8329890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and clinical specificity of 26 symptomatic carriers for dystrophinopathies at pediatric age.
    Mercier S; Toutain A; Toussaint A; Raynaud M; de Barace C; Marcorelles P; Pasquier L; Blayau M; Espil C; Parent P; Journel H; Lazaro L; Andoni Urtizberea J; Moerman A; Faivre L; Eymard B; Maincent K; Gherardi R; Chaigne D; Ben Yaou R; Leturcq F; Chelly J; Desguerre I
    Eur J Hum Genet; 2013 Aug; 21(8):855-63. PubMed ID: 23299919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-chromosome methylation in manifesting and healthy carriers of dystrophinopathies: concordance of activation ratios among first degree female relatives and skewed inactivation as cause of the affected phenotypes.
    Azofeifa J; Voit T; Hübner C; Cremer M
    Hum Genet; 1995 Aug; 96(2):167-76. PubMed ID: 7635465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of new paternal dystrophin gene mutations in isolated cases of dystrophinopathy in females.
    Pegoraro E; Schimke RN; Arahata K; Hayashi Y; Stern H; Marks H; Glasberg MR; Carroll JE; Taber JW; Wessel HB
    Am J Hum Genet; 1994 Jun; 54(6):989-1003. PubMed ID: 8198142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcolemmal distribution of abnormal dystrophin in Xp21 carriers.
    Vainzof M; Nicholson LV; Bulman DE; Tsanaclis AM; Passos-Bueno MR; Pavanello RC; Zatz M
    Neuromuscul Disord; 1993 Mar; 3(2):135-40. PubMed ID: 7689380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skewed X inactivation in manifesting carriers of Duchenne muscular dystrophy.
    Yoshioka M; Yorifuji T; Mituyoshi I
    Clin Genet; 1998 Feb; 53(2):102-7. PubMed ID: 9611069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal and dystrophin-deficient muscle fibers in carriers of the gene for Duchenne muscular dystrophy.
    Bonilla E; Schmidt B; Samitt CE; Miranda AF; Hays AP; de Oliveira AB; Chang HW; Servidei S; Ricci E; Younger DS
    Am J Pathol; 1988 Dec; 133(3):440-5. PubMed ID: 3059802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic counseling of isolated carriers of Duchenne muscular dystrophy.
    Hoffman EP; Pegoraro E; Scacheri P; Burns RG; Taber JW; Weiss L; Spiro A; Blattner P
    Am J Med Genet; 1996 Jun; 63(4):573-80. PubMed ID: 8826437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordance of muscular dystrophy in monozygotic female twins: evidence supporting asymmetric splitting of the inner cell mass in a manifesting carrier of Duchenne dystrophy.
    Lupski JR; Garcia CA; Zoghbi HY; Hoffman EP; Fenwick RG
    Am J Med Genet; 1991 Sep; 40(3):354-64. PubMed ID: 1683155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.